- Home
- FRGE vs XGN Comparison
FRGE vs XGN Comparison
Compare FRGE & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRGE
- XGN
- Stock Information
- Founded
- FRGE 2014
- XGN 2002
- Country
- FRGE United States
- XGN United States
- Employees
- FRGE N/A
- XGN N/A
- Industry
- FRGE Computer Software: Prepackaged Software
- XGN Medical Specialities
- Sector
- FRGE Technology
- XGN Health Care
- Exchange
- FRGE Nasdaq
- XGN Nasdaq
- Market Cap
- FRGE 262.8M
- XGN 253.9M
- IPO Year
- FRGE N/A
- XGN 2019
- Fundamental
- Price
- FRGE $19.75
- XGN $11.85
- Analyst Decision
- FRGE Buy
- XGN Strong Buy
- Analyst Count
- FRGE 5
- XGN 6
- Target Price
- FRGE $35.50
- XGN $12.83
- AVG Volume (30 Days)
- FRGE 108.9K
- XGN 234.3K
- Earning Date
- FRGE 11-04-2025
- XGN 11-04-2025
- Dividend Yield
- FRGE N/A
- XGN N/A
- EPS Growth
- FRGE N/A
- XGN N/A
- EPS
- FRGE N/A
- XGN N/A
- Revenue
- FRGE $90,840,000.00
- XGN $58,862,000.00
- Revenue This Year
- FRGE $32.73
- XGN $22.50
- Revenue Next Year
- FRGE $21.74
- XGN $14.19
- P/E Ratio
- FRGE N/A
- XGN N/A
- Revenue Growth
- FRGE 14.78
- XGN 3.89
- 52 Week Low
- FRGE $6.60
- XGN $2.38
- 52 Week High
- FRGE $24.90
- XGN $12.23
- Technical
- Relative Strength Index (RSI)
- FRGE 62.19
- XGN 67.05
- Support Level
- FRGE $16.16
- XGN $11.58
- Resistance Level
- FRGE $22.20
- XGN $12.23
- Average True Range (ATR)
- FRGE 1.31
- XGN 0.34
- MACD
- FRGE 0.41
- XGN -0.02
- Stochastic Oscillator
- FRGE 61.72
- XGN 73.79
About FRGE Forge Global Holdings Inc.
Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.